Notices

Proposition 65 notices, documents and downloads.  Search using keyword(s) or use the advanced search to include more search options.

Proposition 65 Notices

Oct 31, 2011: Extension of Comment Period - Proposed Amendment To Section 25707(B), Route of Exposure: Hexavalent Chromium (VI)

Extension of public comment period regarding the removal of the reference to hexavalent chromium in Section 25707(b)(4) as posing no significant risk when ingested. 

Oct 28, 2011: tris(1,3-dichloro-2-propyl) phosphate (TDCPP) Listed Effective October 28, 2011 as Known to the State to Cause Cancer

Tris(1,3-dichloro-2-propyl) phosphate (TDCPP) was listed effective 10/28/2011 as known to the State to cause cancer.

Oct 27, 2011: Hearing - Proposed Amendment To Section 25705 Specific Regulatory Levels Posing No Significant Risk: Imazalil

Extension of comment period regarding the establishment of a specific regulatory level posing no significant risk for Imazalil.

Oct 26, 2011: Notice of Adoption to Text of Regulations Title 27, California Code of Regulations Amendment to Section 25805 Maximum Allowable Dose Level (MADL) for Avermectin B1

Notice of adoption to text of regulations Title 27, California Code of Regulations amendment to section 25805 Maximum Allowable Dose Level (MADL) for Avermectin B1

Oct 24, 2011: Extension of Comment Period - Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI)

Extension of public comment period on the changed notice of proposed rulemaking establishing a  No Significant Risk Level: 4-Methylimidazole (4-MEI).

Oct 12, 2011: Carcinogen Identification Committee Meeting Scheduled for October 12 and 13, 2011

Announcement of the October 12th and 13th2011 CIC meeting and hazard ID materials for fluoride and its salts, and tris(1,3-Dichloro-2-Propyl) phosphate.  Both will be considered for listing at the October 2011 meeting.

Oct 7, 2011: Comment Period - Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI)

Comment period for the Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI).

Oct 7, 2011: Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI)

The proposed NSRL for 4-MEI has been changed from 16 to to 29 micrograms per day.

Sep 23, 2011: Comment Period - Proposed Amendment To Section 25705 Specific Regulatory Levels Posing No Significant Risk: Imazalil

Notice to propose establishment of a specific regulatory level posing no significant risk for imazalil and amend Title 27, California Code of Regulations, section 25705.

Sep 23, 2011: Notice of Withdrawal and Resubmittal of Proposed Rulemaking Amendment to Section 25705 Specific Regulatory Levels Posing No Significant Risk: Imazalil

A notice to establish a specific regulatory level posing no significant risk for imazalil was posted on the OEHHA website and published in the CRNR on September 9, 2011. OEHHA is withdrawing that notice because a number of non-substantive, clarifying changes to the notice were required.

Sep 16, 2011: Notice of Intent to List Chemicals: Estrogen–progestogen (combined) used as menopausal therapy, Etoposide, Etoposide in combination with cisplatin and bleomycin, Methyl isobutyl ketone, MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture)

Intent to list chemicals by the labor code mechanism: Estrogen–progestogen (combined) used as menopausal therapy, etoposide, etoposide in combination with cisplatin and bleomycin, methyl isobutyl ketone, MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture).

Sep 16, 2011: Comment Period - Proposed Amendment To Section 25707(B), Route of Exposure: Hexavalent Chromium (VI)

Proposal to amend Section 25707, which would remove the reference to hexavalent chromium in Section 25707(b)(4) as posing no significant risk when ingested, based on recent scientific findings that establish that chromium (hexavalent compounds) can be carcinogenic by the oral route.

Sep 16, 2011: Proposed Amendment To Section 25707(B), Route of Exposure: Hexavalent Chromium (VI)

This amendment would remove the reference to hexavalent chromium in Section 25707(b)(4) as posing no significant risk when ingested, based on recent scientific findings that establish that chromium (hexavalent compounds) can be carcinogenic by the oral route.

Sep 2, 2011: Proposed Amendment of Section 25903 Notices of Violation

This action would amend existing procedures governing service of a 60-day notice under Proposition 65 by establishing an alternative procedure for serving notices on the Attorney General via electronic mail.

Sep 2, 2011: Chemical Listed Effective September 2, 2011 as Known to the State of California to Cause Cancer: titanium dioxide (airborne, unbound particles of respirable size)

OEHHA is adding titanium dioxide (airborne, unbound particles of respirable size) to the list of chemicals known to the state of California to cause cancer for purposes of the Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65).

Aug 3, 2011: 2nd Extension of Comment Period - Request for Relevant Information on Chemicals being Considered for Listing by the Authoritative Bodies Mechanism: Hydrogen Cyanide and Cyanide Salts

On June 24, 2011, the California Environmental Protection Agency’s (Cal/EPA) Office of Environmental Health Hazard Assessment (OEHHA) published a notice extending the public comment period soliciti

Jul 29, 2011: α-Methyl styrene Listed Effective July 29, 2011 as Known to the State of California to Cause Reproductive Toxicity

Addition of α-methyl styrene (CAS No. 98-83-9) to the list of chemicals known to the state to cause reproductive toxicity for purposes of the Safe Drinking Water and Toxic Enforcement Act of 1986.

Pages